Abdominoplasty Improves Quality of Life, Psychological Distress, and Eating Disorder Symptoms: A Prospective Study. (23rd November 2014)

• Record Type: Journal Article
• Authors: Saariniemi, Kai M. M.; Salmi, Asko M.; Peltoniemi, Hilkka H.; Helle, Marjo H.; Charpentier, Pia; Kuokkanen, Hannu O. M.
• Other Names: Özmen Selahattin Academic Editor.
• Is Part Of: Plastic surgery international. Volume 2014(2014)
• Publication Date: 2014-11-23
• Subjects: Surgery, Plastic -- Periodicals; 617.95205
• DOI: 10.1155/2014/197232
• Languages: English
• ISSNs: 2090-1461

Abstract

Abstract : Background . Only some studies provide sufficient data regarding the effects of nonpostbariatric (aesthetic) abdominoplasty on various aspects of quality of life. Nevertheless, when considering the effects on eating habits, publications are lacking. Therefore we decided to assess the effects of nonpostbariatric abdominoplasty on eating disorder symptoms, psychological distress, and quality of life. Materials and Methods . 64 consecutive women underwent nonpostbariatric abdominoplasty. Three outcome measures were completed: the Eating Disorder Inventory (EDI), Raitasalo's modification of the Beck Depression Inventory (RBDI), and the 15D general quality of life questionnaire. Results . The mean age at baseline was 42 years and the mean body mass index (BMI) 26.4. Fifty-three (83%) women completed all the outcome measures with a mean follow-up time of 5 months. A significant improvement from baseline to follow-up was noted in women's overall quality of life, body satisfaction, effectiveness, sexual functioning, and self-esteem. The women were significantly less depressive and had significantly less drive for thinness as well as bulimia, and their overall risk of developing an eating disorder also decreased significantly. Conclusions . Abdominoplasty results in significantly improved quality of life, body satisfaction, effectiveness, sexual functioning, self-esteem, and mental health. The risk of developing an eating disorder is decreased significantly. This trial is registered with Clinicaltrials.gov NCT02151799 .